621 related articles for article (PubMed ID: 9916804)
21. Role of central melanocortin signaling in eating disorders.
Lu XY
Psychopharmacol Bull; 2001; 35(4):45-65. PubMed ID: 12397856
[TBL] [Abstract][Full Text] [Related]
22. Melanocortins and body weight: a tale of two receptors.
Cummings DE; Schwartz MW
Nat Genet; 2000 Sep; 26(1):8-9. PubMed ID: 10973234
[No Abstract] [Full Text] [Related]
23. Effect of neuropeptide B on feeding behavior is influenced by endogenous corticotropin-releasing factor activities.
Aikawa S; Ishii M; Yanagisawa M; Sakakibara Y; Sakurai T
Regul Pept; 2008 Nov; 151(1-3):147-52. PubMed ID: 18760311
[TBL] [Abstract][Full Text] [Related]
24. Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat.
Edwards CM; Abbott CR; Sunter D; Kim M; Dakin CL; Murphy KG; Abusnana S; Taheri S; Rossi M; Bloom SR
Brain Res; 2000 Jun; 866(1-2):128-34. PubMed ID: 10825488
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.
Arasasingham PN; Fotsch C; Ouyang X; Norman MH; Kelly MG; Stark KL; Karbon B; Hale C; Baumgartner JW; Zambrano M; Cheetham J; Tamayo NA
J Med Chem; 2003 Jan; 46(1):9-11. PubMed ID: 12502354
[TBL] [Abstract][Full Text] [Related]
26. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
Haskell-Luevano C; Cone RD; Monck EK; Wan YP
Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
[TBL] [Abstract][Full Text] [Related]
27. Neuromedin U-induced anorexigenic action is mediated by the corticotropin-releasing hormone receptor-signaling pathway in goldfish.
Maruyama K; Wada K; Ishiguro K; Shimakura S; Wakasugi T; Uchiyama M; Shioda S; Matsuda K
Peptides; 2009 Dec; 30(12):2483-6. PubMed ID: 19699772
[TBL] [Abstract][Full Text] [Related]
28. Possible involvement of melanocortin-4-receptor and AMP-activated protein kinase in the interaction of glucagon-like peptide-1 and leptin on feeding in rats.
Poleni PE; Akieda-Asai S; Koda S; Sakurai M; Bae CR; Senba K; Cha YS; Furuya M; Date Y
Biochem Biophys Res Commun; 2012 Mar; 420(1):36-41. PubMed ID: 22390932
[TBL] [Abstract][Full Text] [Related]
29. Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues.
Marsh DJ; Miura GI; Yagaloff KA; Schwartz MW; Barsh GS; Palmiter RD
Brain Res; 1999 Nov; 848(1-2):66-77. PubMed ID: 10612698
[TBL] [Abstract][Full Text] [Related]
30. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
Raposinho PD; Castillo E; d'Alleves V; Broqua P; Pralong FP; Aubert ML
Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
[TBL] [Abstract][Full Text] [Related]
31. The anorexigenic action of the octadecaneuropeptide (ODN) in goldfish is mediated through the MC4R- and subsequently the CRH receptor-signaling pathways.
Matsuda K; Kojima K; Wada K; Maruyama K; Leprince J; Tonon MC; Uchiyama M; Vaudry H
J Mol Neurosci; 2010 Sep; 42(1):74-9. PubMed ID: 20306309
[TBL] [Abstract][Full Text] [Related]
32. The anorexic effect of alpha-melanocyte-stimulating hormone is mediated by corticotrophin-releasing factor in chicks.
Tachibana T; Oikawa D; Takahashi H; Boswell T; Furuse M
Comp Biochem Physiol A Mol Integr Physiol; 2007 May; 147(1):173-8. PubMed ID: 17321768
[TBL] [Abstract][Full Text] [Related]
33. The melanocortin pathway and control of appetite-progress and therapeutic implications.
Baldini G; Phelan KD
J Endocrinol; 2019 Apr; 241(1):R1-R33. PubMed ID: 30812013
[TBL] [Abstract][Full Text] [Related]
34. [Psychiatric disorders and neural mechanisms underlying energy intake and expenditure: a review].
Kishi T; Horiguchi J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct; 23(5):197-203. PubMed ID: 14653225
[TBL] [Abstract][Full Text] [Related]
35. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
36. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
Raposinho PD; White RB; Aubert ML
J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
[TBL] [Abstract][Full Text] [Related]
37. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
38. Regulation of adipose tissue leptin secretion by alpha-melanocyte-stimulating hormone and agouti-related protein: further evidence of an interaction between leptin and the melanocortin signalling system.
Hoggard N; Hunter L; Duncan JS; Rayner DV
J Mol Endocrinol; 2004 Feb; 32(1):145-53. PubMed ID: 14765998
[TBL] [Abstract][Full Text] [Related]
39. Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice.
da Silva AA; Freeman JN; Hall JE; do Carmo JM
Am J Physiol Regul Integr Comp Physiol; 2018 Apr; 314(4):R533-R539. PubMed ID: 29351428
[TBL] [Abstract][Full Text] [Related]
40. Plasma agouti-related protein levels in women with anorexia nervosa.
Moriya J; Takimoto Y; Yoshiuchi K; Shimosawa T; Akabayashi A
Psychoneuroendocrinology; 2006 Oct; 31(9):1057-61. PubMed ID: 16904835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
